Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: AstraZeneca PLC

Market Cap 278B 244B 225B 211B 395B 26,349B 402B 2,704B 1,047B 12,928B 1,044B 1,022B 44,933B P/E 2026 *
22.5x
P/E 2027 * 19.6x
Enterprise Value 297B 261B 241B 225B 422B 28,172B 429B 2,891B 1,119B 13,823B 1,116B 1,092B 48,042B EV / Sales 2026 *
4.7x
EV / Sales 2027 * 4.32x
Free-Float
96.63%
Yield 2026 *
1.86%
Yield 2027 * 1.97%
1 day+2.26%
1 week+2.30%
Current month-1.54%
1 month-2.34%
3 months-1.11%
6 months-1.06%
Current year-1.45%
1 week 13,116
Extreme 13116
15,126
1 month 11,232
Extreme 11232
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,103
Extreme 10103
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,994.5
Extreme 3994.5
15,732
Manager TitleAgeSince
Chief Executive Officer 66 30/09/2012
Director of Finance/CFO 52 31/07/2021
Chief Operating Officer 55 31/05/2015
Director TitleAgeSince
Director/Board Member 70 05/04/1999
Director/Board Member 66 30/09/2012
Director/Board Member 65 26/04/2017
Date Insider Type Main position Quantity % Market Cap.
06-07Free

See Remarks

1 0.0000%
05-19Sell

See Remarks

-11,893 0.0008%
05-13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+2.26%+2.30%+30.42%+18.98% 278B
+0.45%-1.37%+43.66%+141.28% 987B
+3.37%+1.66%+58.00%+44.48% 576B
+2.07%+5.52%+27.75%+72.72% 415B
+0.25%-1.30%+22.76%+15.66% 320B
+2.61%+3.11%+29.81%+36.09% 279B
+2.60%+9.79%-31.71%-43.45% 208B
+0.66%-0.24%+27.37%+52.79% 187B
+0.14%-1.71%+17.76%+61.42% 155B
-1.44%-5.07%+2.87%-35.46% 141B
Average +1.29%+1.01%+22.87%+36.45% 354.61B
Weighted average by Cap. +1.44%+0.56%+32.08%+62.33%

Financials

2026 *2027 *
Net sales 63.32B 55.63B 51.26B 47.98B 89.9B 5,998B 91.42B 615B 238B 2,943B 238B 233B 10,229B 67.16B 59B 54.36B 50.89B 95.35B 6,362B 96.96B 653B 253B 3,121B 252B 247B 10,849B
Net income 12.49B 10.97B 10.11B 9.46B 17.73B 1,183B 18.03B 121B 46.99B 580B 46.88B 45.87B 2,017B 14.14B 12.42B 11.44B 10.71B 20.07B 1,339B 20.41B 137B 53.19B 657B 53.07B 51.93B 2,284B
Net Debt 19.25B 16.91B 15.58B 14.58B 27.32B 1,823B 27.78B 187B 72.41B 895B 72.25B 70.69B 3,109B 12.01B 10.55B 9.72B 9.1B 17.04B 1,137B 17.33B 117B 45.17B 558B 45.07B 44.1B 1,939B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
23/06/26 GBX 13,590.00 +2.26% 1,873,019
22/06/26 GBX 13,290.00 +0.42% 1,821,832
19/06/26 GBX 13,234.00 +0.61% 4,448,738
18/06/26 GBX 13,154.00 -2.36% 1,591,360
17/06/26 GBX 13,472.00 +1.42% 1,420,705
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
179.34USD
Average target price
220.86USD
Spread / Average Target
+23.15%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!